Application of metabolism and pharmacokinetic studies to the drug discovery process

Drug Metabolism Reviews

Volumn 28, Issue 3, 1996, Pages 473-489

  Humphrey, M J ^a  

^a PFIZER GLOBAL RESEARCH AND DEVELOPMENT   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

AMLODIPINE; ANTIARRHYTHMIC AGENT; ANTIFUNGAL AGENT; CALCIUM ANTAGONIST; CANDOXATRIL; DOFETILIDE; FLUCONAZOLE; SOTALOL;

CHEMICAL STRUCTURE; DATA ANALYSIS; DRUG DESIGN; DRUG DEVELOPMENT; DRUG METABOLISM; HUMAN; NONHUMAN; PHARMACOKINETICS; REVIEW; STRUCTURE ACTIVITY RELATION;

EID: 0029768719     PISSN: 03602532     EISSN: None     Source Type: Journal    
DOI: 10.3109/03602539608994012     Document Type: Review

References (32)

1. M. J. Humphrey and D. A. Smith, Xenobiotica, 22, 743-755 (1992).
2. D. A. Smith, M. J. Humphrey, and C. Charuel, Xenobiotica, 20, 1185-1199 (1990).
3. D. A. Smith, Eur. J. Drug Metab. Pharmacokinet. 19, 193-199 (1994).
4. J. C. Danilewicz et al., Biochem. Biophys. Res. Commun., 164, 58-65 (1989).
5. D. C. Taylor, Pharm. Int., 7, 179-183 (1986).
6. D. I. Friedman and G. L. Amidon, J. Controlled Release, 13, 141-146 (1990).
7. N. J. Cussans. Br. J. Clin. Pharmacol., 34, 171P (1992).
8. K. Richardson, K. Cooper, M. S. Marriott, M. H. Tarbit, P. F. Troke, and P. J. Whittle, Rev. Infect. Dis., 12, S267-S271 (1990).
9. M. H. Tarbit, In Handbook of Experimental Pharmacology (J. Ryley, .ed.), Springer-Verlag, Berlin, 1990, Vol. 96, Chap. 7, pp. 183-204.
10. H. L. Bomont, M. H. Tarbit, M. J. Humphrey, and J. B. Houston, Pharm. Res., 11, 951-960 (1994).
11. M. J. Humphrey, S. Jevons, and M. J. Tarbit, Antimicrobial Agents Chemother, 28, 648-653 (1985).
12. S. G. Jezequel, J. Pharm. Pharmacol., 46, 196-199 (1994).
13. R. C. Klein et al., Am. Heart J., 114, 551-558 (1987).
14. A. M. Gillis and R. E. Kates, Clin. Pharmacokinet., 9, 375-403 (1984).
15. S. B. Olsson, Class III antiarrhythmic action, in Handbook of Experimental Pharmacology, Springer-Verlag, 1989, Vol. 89, pp. 324-327.
16. J. M. Poirier, P. Jaillon, V. Lacocq, A. Ferry, and G. Cheymol, Eur. J. Clin. Pharmacol., 38, 579-582 (1990).
17. D. A. Smith, H. S. Rasmussen, D. A. Stopher, and D. K. Walker, Xenobiotica, 22, 709-719 (1992).
18. D. K. Walker, C. T. Alabaster, G. S. Congrave, B. C. Jones, and D. A. Smith, Br. J. Clin. Pharmacol., 37, 499-500P (1994).
19. D. R. Abernethy and J. B. Schwartz, Clin. Pharmacokinet., 15, 1-4 (1988).
20. J. E. Arrowsmith, S. F. Campbell, P. E. Cross, J. K. Stubbs, R. A. Burges, D. G. Gardiner, and K. J. Blackburn, J. Med. Chem., 29, 1696-1702 (1986).
21. A. B. Beresford, M. J. Humphrey, and D. A. Stopher, Br. J. Pharmacol., 85, 333P (1985).
22. D. Alker et al., J. Chem. Soc. Perkin Trans., 2, 1137-1140 (1992).
23. R. P. Mason, S. F. Campbell, Wang Shou-Dao, and L. G. Herbette, Mol. Pharmacol., 36, 634-640 (1989).
24. M. J. Humphrey and D. A. Smith, Br. J. Clin. Pharmacol., 33, 291P (1992).
25. D. K. Walker, M. J. Humphrey, and D. A. Smith, Xenobiotica, 24, 243-250 (1994).
26. A. D. Bainbridge, O. Herlihy, P. A. Meredith, and H. L. Elliott, Eur. J. Clin. Pharmacol., 45, 425-430 (1993).
27. R. A. Prends, Y. Lis, and S. P. Walker, Br. J. Clin. Pharmacol., 25, 387-396 (1988).
28. M. H. Tarbit, Biochem. Soc. Trans., 21, 1018-1023 (1993).
29. D. A. Smith, Drug Metab. Rev., 23, 255-274 (1991).
30. D. J. Nichols, P. E. Coates, R. A. Ronfeld, and D. A. Smith, in International Pharmaceutical Product Registration: Aspects of Quality and Efficacy (A. C. Cartwright and B. R. Mathews, eds.), Ellis Horwood, 1994, Chap. 19.
31. C. C. Peck et al., Pharm Res., 9, 826-833 (1992).
32. D. A. Smith and B. C. Jones, Biochem. Pharmacol., 44, 2089-2098 (1992).